In the initial NADIM trial, neoadjuvant chemoimmunotherapy was shown to be highly effective in patients with resectable stage IIIA non-small […]

Patients with lung cancer who attended a lung cancer screening event and who then participated in a personalized smoking cessation […]

Lung cancer screening using low-dose computed tomography would prevent more than 18,000 premature lung cancer deaths at a cost of […]

The use of Stereotactic Body Radiotherapy (SBRT) for patients with non-small cell lung cancer can reduce treatment disparities between White […]

The protocol used to screen and detect lung cancer in the NELSON Trial is more sensitive than the protocol used […]

Using data from the National Lung Screening Trial, researchers found that the incidence of second primary lung cancer was approximately […]

Researchers from Spain have identified an immune expression signature in surgical specimens associated with disease progression for non-complete pathological responders […]